Innovation Pharmaceuticals Inc (IPIX): How about B for all indications except A...

Reply Private New

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Re: Lemoncat post# 391438

Thursday, 07/21/2022 12:47:14 PM

Thursday, July 21, 2022 12:47:14 PM

How about B for all indications except AlfaSigma's?

That would be sweet for shareholders and good risk/reward for BP, in my opinion.

I don't know who would give us $100M upfront or on what but that's another question.

Keep Last Read

Replies (4) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

Only $200 per official company press release!